RxDoctor Payments Data

Ghassan Abdallah, MD

Family Medicine · Middleburg Heights, OHNPI 1265531859

Payments from drug & device makers

$1,111in general payments, 2019–2025

Across 56 payments — averaging $19.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$266
  • Medtronic$139
  • Abbott$124
  • Bayer$83
  • Dexcom, Inc.$74
  • Novartis$72
  • plus $355 from 11 others

What the payments were for

  • Food & beverage$1,111100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,111 in reported general payments places this provider in the 65th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$165,163
Medicare patients
449
Services billed
3,464

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban112$122,591
OzempicSemaglutide51$56,800
Trelegy ElliptaFluticasone/Umeclidin/Vilanter48$39,526
JardianceEmpagliflozin24$39,268
XareltoRivaroxaban24$27,473
EntrestoSacubitril/Valsartan16$20,524
JanuviaSitagliptin Phosphate34$19,278
TrulicityDulaglutide14$11,693
Atorvastatin Calcium737$7,539
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate12$5,680
Lantus SolostarInsulin Glargine,hum.Rec.Anlog22$5,415
Repatha SyringeEvolocumab11$4,741
Levothyroxine Sodium375$4,453
Tamsulosin Hcl273$4,080
Metoprolol Succinate215$3,319

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$58$122,591112 claims
Novo NordiskOzempic$56$56,80051 claims
GSKTrelegy Ellipta$38$39,52648 claims
Johnson & JohnsonXarelto$19$27,47324 claims
NovartisEntresto$72$20,52416 claims
MerckJanuvia$32$19,27834 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Middleburg Heights

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →